DE PONTI, FABRIZIO
DE PONTI, FABRIZIO
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
Anticancer drugs and depression through the lens of disproportionality analysis: unveiling underlying confounders and tips for prescribers
2026 Raschi, E.; Nannini, M.; Montastruc, F.; Khouri, C.; Poluzzi, E.; De Ponti, F.
Contemporary local anaesthetic-associated adverse events and mortality: searching for the root causes of the pharmacovigilance signal. Br J Anaesth 2026;136:411–13
2026 Raschi, E.; Tonetti, T.; Khouri, C.; Poluzzi, E.; De Ponti, F.
Barriers and solutions for the European prescribing exam: a qualitative world café study
2025 Donker, E. M.; Piët, J. D.; Brinkman, D. J.; Richir, M. C.; Papaioannidou, P.; Likic, R.; Sanz, E. J.; Christiaens, T.; Costa, J. N.; De Ponti, F.; Gatti, M.; Böttiger, Y.; Kramers, C.; Van Agtmael, M. A.; Tichelaar, J.
Disproportionality analysis on semaglutide and nonarteritic anterior ischemic optic neuropathy in the FDA adverse event reporting system: An emerging pharmacovigilance signal?
2025 Procacci, Angela; Poluzzi, Elisabetta; De Ponti, Fabrizio; Raschi, Emanuel
Long-term surveillance of the anti-amyloid monoclonal antibody lecanemab: rights and duties of pharmacovigilance
2025 Donati, Monia; Boccia, Angela; De Ponti, Fabrizio; Poluzzi, Elisabetta; Raschi, Emanuel
Toward the harmonization of bioequivalence guidelines in Europe: Commentary on the state of the art and future priorities under ICH M13A for immediate‐release oral forms
2025 Nocera, Domenico; Forastiero, Giusi; Logreco, Andrea; Proietti, Alessia; Galluccio, Antonio; Lunghi, Carlotta; Poluzzi, Elisabetta; De Ponti, Fabrizio
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals
2024 Lunghi C.; Domenicali M.; Vertullo S.; Raschi E.; De Ponti F.; Onder G.; Poluzzi E.
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System
2024 Cecco, S.; Puligheddu, S.; Fusaroli, M.; Gerratana, L.; Yan, M.; Zamagni, C.; De Ponti, F.; Raschi, E.
Enhancing therapeutic reasoning: key insights and recommendations for education in prescribing
2024 Hartjes, M. G.; Richir, M. C.; Cazaubon, Y.; Donker, E. M.; van Leeuwen, E.; Likic, R.; Pers, Y. M.; Piët, J. D.; De Ponti, F.; Raasch, W.; van Rosse, F.; Rychlícková, J.; Sanz, E. J.; Schwaninger, M.; Wallerstedt, S. M.; de Vries, T. P. G. M.; van Agtmael, M. A.; Tichelaar, J.
Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation
2024 Piët, J. D.; Booth, A.; Donker, E. M.; de Ponti, F.; Lunghi, C.; Poluzzi, E.; Janssen, B. J. A.; Tun, S. Y. M.; Bekker, C.; Dima, L.; Costa, J.; Jalving, M.; Oude Munnink, T. H.; van den Bemt, P. M. L. A.; Labriffe, M.; van Emden, T.; van Waardenburg, V.; Likic, R.; Richir, M.; van Agtmael, M. A.; Moermond, C. T. A.; Tichelaar, J.
Implementing Clinical Case Discussions to Enhance Clinical Reasoning Skills: A Pilot Study in an Italian Medical School
2024 Colonnello, Valentina; Zodl, Aurelia; Agnoletti, Davide; Lischeid, Kilian; Cimbalnik, Lena; Weidenbusch, Marc; R Fischer, Martin; De Ponti, Fabrizio; Rausch, Christian
Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward
2024 Poluzzi E.; Raschi E.; Lunghi C.; Bertuccio A.; Eleftheriou A.; De Ponti F.
Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports A Note of Caution
2024 Fusaroli, M.; Khouri, C.; Poluzzi, E.; De Ponti, F.; Salvo, F.; Raschi, E.
Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis
2024 Raschi, E.; Salvo, F.; Bate, A.; De Ponti, F.; Poluzzi, E.; Tuccori, M.; van Puijenbroek, E.; Joshi, N.; Khouri, C.
The European List of Key Medicines for Medical Education: A Modified Delphi Study
2024 Donker, Erik M; Spitaleri Timpone, Pietro; Brinkman, David J; Richir, Milan C; Papaioannidou, Paraskevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; De Ponti, Fabrizio; Gatti, Milo; Böttiger, Ylva; Kramers, Cornelis; Pandit, Rahul; van Agtmael, Michiel A; Tichelaar, Jelle
Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System
2024 Fusaroli, M.; Polizzi, S.; Menestrina, L.; Giunchi, V.; Pellegrini, L.; Raschi, E.; Weintraub, D.; Recanatini, M.; Castellani, G.; De Ponti, F.; Poluzzi, E.
Using artificial intelligence to create diverse and inclusive medical case vignettes for education
2024 Bakkum, Michiel J; Hartjes, Mariëlle G; Piët, Joost D; Donker, Erik M; Likic, Robert; Sanz, Emilio; de Ponti, Fabrizio; Verdonk, Petra; Richir, Milan C; van Agtmael, Michiel A; Tichelaar, Jelle
A clinical pharmacology and therapeutics teacher's guide to race-based medicine, inclusivity, and diversity
2023 Bakkum, Michiel J; Verdonk, Petra; Thomas, Elias G; van Rosse, Floor; Okorie, Michael; Papaioannidou, Paraskevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; Dima, Lorena; de Ponti, Fabrizio; van Smeden, Jeroen; van Agtmael, Michiel A; Richir, Milan C; Tichelaar, Jelle
Antipsychotics and Drug-Induced Liver Injury
2023 Raschi, Emanuel; Schoretsanitis, Georgios; Gastaldon, Chiara; Khouri, Charles; Salvo, Francesco; De Ponti, Fabrizio
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System
2023 Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Ponti F.; Pelotti S.; Poluzzi E.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Anticancer drugs and depression through the lens of disproportionality analysis: unveiling underlying confounders and tips for prescribers | Raschi, E.; Nannini, M.; Montastruc, F.; Khouri, C.; Poluzzi, E.; De Ponti, F. | 2026-01-01 | JOURNAL OF AFFECTIVE DISORDERS | - | 1.01 Articolo in rivista | - |
| Contemporary local anaesthetic-associated adverse events and mortality: searching for the root causes of the pharmacovigilance signal. Br J Anaesth 2026;136:411–13 | Raschi, E.; Tonetti, T.; Khouri, C.; Poluzzi, E.; De Ponti, F. | 2026-01-01 | BRITISH JOURNAL OF ANAESTHESIA | - | 1.04 Replica / breve intervento (e simili) | - |
| Barriers and solutions for the European prescribing exam: a qualitative world café study | Donker, E. M.; Piët, J. D.; Brinkman, D. J.; Richir, M. C.; Papaioannidou, P.; Likic, R.; Sanz, E.... J.; Christiaens, T.; Costa, J. N.; De Ponti, F.; Gatti, M.; Böttiger, Y.; Kramers, C.; Van Agtmael, M. A.; Tichelaar, J. | 2025-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | s00228-025-03886-8.pdf |
| Disproportionality analysis on semaglutide and nonarteritic anterior ischemic optic neuropathy in the FDA adverse event reporting system: An emerging pharmacovigilance signal? | Procacci, Angela; Poluzzi, Elisabetta; De Ponti, Fabrizio; Raschi, Emanuel | 2025-01-01 | OBESITY RESEARCH & CLINICAL PRACTICE | - | 1.01 Articolo in rivista | - |
| Long-term surveillance of the anti-amyloid monoclonal antibody lecanemab: rights and duties of pharmacovigilance | Donati, Monia; Boccia, Angela; De Ponti, Fabrizio; Poluzzi, Elisabetta; Raschi, Emanuel | 2025-01-01 | ALZHEIMER'S RESEARCH & THERAPY | - | 1.01 Articolo in rivista | 13195_2025_Article_1699.pdf |
| Toward the harmonization of bioequivalence guidelines in Europe: Commentary on the state of the art and future priorities under ICH M13A for immediate‐release oral forms | Nocera, Domenico; Forastiero, Giusi; Logreco, Andrea; Proietti, Alessia; Galluccio, Antonio; Lung...hi, Carlotta; Poluzzi, Elisabetta; De Ponti, Fabrizio | 2025-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | BRJCLI~1.PDF |
| Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals | Lunghi C.; Domenicali M.; Vertullo S.; Raschi E.; De Ponti F.; Onder G.; Poluzzi E. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | Lunghi et al. Drug Safety 2024.pdf; 40264_2024_1453_MOESM1_ESM.pdf |
| Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System | Cecco, S.; Puligheddu, S.; Fusaroli, M.; Gerratana, L.; Yan, M.; Zamagni, C.; De Ponti, F.; Rasch...i, E. | 2024-01-01 | TARGETED ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Enhancing therapeutic reasoning: key insights and recommendations for education in prescribing | Hartjes, M. G.; Richir, M. C.; Cazaubon, Y.; Donker, E. M.; van Leeuwen, E.; Likic, R.; Pers, Y. ...M.; Piët, J. D.; De Ponti, F.; Raasch, W.; van Rosse, F.; Rychlícková, J.; Sanz, E. J.; Schwaninger, M.; Wallerstedt, S. M.; de Vries, T. P. G. M.; van Agtmael, M. A.; Tichelaar, J. | 2024-01-01 | BMC MEDICAL EDUCATION | - | 1.01 Articolo in rivista | s12909-024-06310-4.pdf |
| Environmentally sustainable prescribing: recommendations for EU pharmaceutical legislation | Piët, J. D.; Booth, A.; Donker, E. M.; de Ponti, F.; Lunghi, C.; Poluzzi, E.; Janssen, B. J. A.; ...Tun, S. Y. M.; Bekker, C.; Dima, L.; Costa, J.; Jalving, M.; Oude Munnink, T. H.; van den Bemt, P. M. L. A.; Labriffe, M.; van Emden, T.; van Waardenburg, V.; Likic, R.; Richir, M.; van Agtmael, M. A.; Moermond, C. T. A.; Tichelaar, J. | 2024-01-01 | THE LANCET. PLANETARY HEALTH | - | 1.04 Replica / breve intervento (e simili) | - |
| Implementing Clinical Case Discussions to Enhance Clinical Reasoning Skills: A Pilot Study in an Italian Medical School | Colonnello, Valentina; Zodl, Aurelia; Agnoletti, Davide; Lischeid, Kilian; Cimbalnik, Lena; Weide...nbusch, Marc; R Fischer, Martin; De Ponti, Fabrizio; Rausch, Christian | 2024-01-01 | INTERNATIONAL MEDICAL EDUCATION | - | 1.01 Articolo in rivista | ime-03-00023.pdf |
| Learning of clinical pharmacology by future prescribers in Bologna: Teachers' and students' reflections on the way forward | Poluzzi E.; Raschi E.; Lunghi C.; Bertuccio A.; Eleftheriou A.; De Ponti F. | 2024-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports A Note of Caution | Fusaroli, M.; Khouri, C.; Poluzzi, E.; De Ponti, F.; Salvo, F.; Raschi, E. | 2024-01-01 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis | Raschi, E.; Salvo, F.; Bate, A.; De Ponti, F.; Poluzzi, E.; Tuccori, M.; van Puijenbroek, E.; Jos...hi, N.; Khouri, C. | 2024-01-01 | DRUG SAFETY | - | 1.04 Replica / breve intervento (e simili) | - |
| The European List of Key Medicines for Medical Education: A Modified Delphi Study | Donker, Erik M; Spitaleri Timpone, Pietro; Brinkman, David J; Richir, Milan C; Papaioannidou, Par...askevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; De Ponti, Fabrizio; Gatti, Milo; Böttiger, Ylva; Kramers, Cornelis; Pandit, Rahul; van Agtmael, Michiel A; Tichelaar, Jelle | 2024-01-01 | CLINICAL PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | Clin Pharma and Therapeutics_2024.pdf |
| Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System | Fusaroli, M.; Polizzi, S.; Menestrina, L.; Giunchi, V.; Pellegrini, L.; Raschi, E.; Weintraub, D....; Recanatini, M.; Castellani, G.; De Ponti, F.; Poluzzi, E. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | s40264-024-01471-z.pdf; 40264_2024_1471_MOESM1_ESM.pdf |
| Using artificial intelligence to create diverse and inclusive medical case vignettes for education | Bakkum, Michiel J; Hartjes, Mariëlle G; Piët, Joost D; Donker, Erik M; Likic, Robert; Sanz, Emili...o; de Ponti, Fabrizio; Verdonk, Petra; Richir, Milan C; van Agtmael, Michiel A; Tichelaar, Jelle | 2024-01-01 | BJCP. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | Brit J Clinical Pharma - 2023 - Bakkum.pdf |
| A clinical pharmacology and therapeutics teacher's guide to race-based medicine, inclusivity, and diversity | Bakkum, Michiel J; Verdonk, Petra; Thomas, Elias G; van Rosse, Floor; Okorie, Michael; Papaioanni...dou, Paraskevi; Likic, Robert; Sanz, Emilio J; Christiaens, Thierry; Costa, João N; Dima, Lorena; de Ponti, Fabrizio; van Smeden, Jeroen; van Agtmael, Michiel A; Richir, Milan C; Tichelaar, Jelle | 2023-01-01 | CLINICAL PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | Clin Pharma and Therapeutics - 2022 - Bakkum - A Clinical Pharmacology and Therapeutics Teacher s Guide to Race‐Based.pdf |
| Antipsychotics and Drug-Induced Liver Injury | Raschi, Emanuel; Schoretsanitis, Georgios; Gastaldon, Chiara; Khouri, Charles; Salvo, Francesco; ...De Ponti, Fabrizio | 2023-01-01 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System | Fusaroli M.; Pelletti G.; Giunchi V.; Pugliese C.; Bartolucci M.; Necibi E.N.; Raschi E.; De Pont...i F.; Pelotti S.; Poluzzi E. | 2023-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | s40264-022-01269-x.pdf; 40264_2022_1269_MOESM1_ESM.pdf |